Hb Wealth Management, LLC Gossamer Bio, Inc. Call Options Transaction History
Hb Wealth Management, LLC
- $14.5 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
158Shares Held
158MCall Options Held
3.23MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$46.1 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$45.4 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$30.1 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$20.2 Million5.25% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$15.4 Million3.24% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $236M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...